iBio
- Pharmaceutical Preparations
- New York, New York
Compensation history
Top executives at iBio received an average of $504K per person in annual compensation from 2008 to 2021.
By year
Executives
We found 12 executives who work or worked at iBio.
Thomas Isett
iBio
Chief Executive Officer
Martin Brenner
iBio
Chief Scientific Officer
Randy Maddux
iBio
Chief Operating Officer
Robert Kay
iBio
Chief Executive Officer
James Mullaney
iBio
Chief Financial Officer
Robert Erwin
iBio
President
Terence Ryan
iBio
Chief Scientific Officer
Mark Giannone
iBio
Chief Financial Officer
News
iBio CEO Thomas Isett's 2021 pay jumps 171% to $4.8M
October 26, 2021
iBio CEO Thomas Isett receives $1.8M in 2020
November 3, 2020
iBio CEO Robert Kay's 2019 pay rises 10% to $348K
January 23, 2020
iBio Chairman Robert Kay's 2018 pay falls 25% to $315K
November 19, 2018
iBio CEO Robert Kay's 2009 pay jumps 2,087% to $202K
October 28, 2009
About iBio
- Industry classifications
- Manufacturing
- Chemicals And Allied Products
- Drugs
- Pharmaceutical Preparations
- 600 Madison Avenue, Suite 1601, New York, New York 10022-1737
- 302 355-0650
- June 30
- Former names
- iBioPharma, Inc.
- InB:Biotechnologies, Inc.